Last updated at 16 Aug 2024 12:46 PM
Director
DIN: 08677161
Nagaraja Rao Abhinandan is currently associated with 3 companies in various capacities such as Partner, Director and CFO. They serve as a Director at K.N. MANASA ENTERPRISES LLP and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08677161.Nagaraja Rao Abhinandan has previously been associated with 1 company in roles such as Additional Director.Nagaraja Rao Abhinandan is currently involved in 3 different roles. Their most recent position is with ADESHWAR MEDITEX LIMITED as a CFO. The first company Nagaraja Rao Abhinandan was appointed to as a director was K.N. MANASA ENTERPRISES LLP. Nagaraja Rao Abhinandan is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Nagaraja Rao Abhinandan is currently associated with 3 companies in various capacities such as Partner, Director and CFO. They serve as a Director at K.N. MANASA ENTERPRISES LLP and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08677161.Nagaraja Rao Abhinandan has previously been associated with 1 company in roles such as Additional Director.Nagaraja Rao Abhinandan is currently involved in 3 different roles. Their most recent position is with ADESHWAR MEDITEX LIMITED as a CFO. The first company Nagaraja Rao Abhinandan was appointed to as a director was K.N. MANASA ENTERPRISES LLP. Nagaraja Rao Abhinandan is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
3
Male
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (1)
Past Companies (1)
1y 3m 8 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| VITRAG BIOFABS PRIVATE LIMITED | Director | 30-Sep-2022 |
| ADESHWAR MEDITEX LIMITED | CFO | 30-Sep-2022 |